Abstract
Background Phytoestrogens are plant-derived, bioactive substances with a chemical structure similar to that of 17-oestradiol. Women previously treated for breast cancer may increase their phytoestrogen intake to avoid conventional hormone replacement therapy or because of a belief that they may help avoid recurrence [1,2]. There is no recommended daily intake and there are some concerns about phytoestrogen safety in this group, although the evidence is conflicting and more research is needed [3,4]. Methods Three hundred and sixteen women each completed a 4- day food and drink diary (14 of whom also completed a 7-day weighed intake diary 6 weeks previously). The 55 most recently recruited women collected their urine for 24 hours whilst completing their diaries and were interviewed by telephone regarding their food choices since diagnosis. Results A new dietary analysis database was created using peerreviewed published data and analysing 34 additional foods and beverages for which there were no published results. The urinanalysis results contributed validation data. A summary of the dietary intake data is shown in Table 1. There was a lack of primary analytical data on the phytoestrogen profile of many foods and beverages routinely consumed by this study population. However, food frequency data from the highest quartile show the important contribution of nonsoya foods to high intakes (Table 2). Telephone interviews were completed by 39 subjects. For most women, having breast cancer had not changed their diet. Health concerns unrelated to cancer, the needs of other family members, cooking on a budget and physical appearance all seemed more important than the impact of the cancer diagnosis. Discussion Variation in phytoestrogen intakes and metabolite excretion reflect food preferences, dietary analysis database limitations and likely variations in existing knowledge combined with a lack of routine access to dietary information. In the absence of definitive advice, more immediate health and social concerns influence food choice rather than past breast cancer diagnosis. Conclusion No data previously existed on intake in this potentially vulnerable group and these data will help evaluate the health implications related to such phytoestrogen consumption patterns. Acknowledgement Funded by the Food Standards Agency, UK. References 1. Adlercreutz H: Phytoestrogens and breast cancer. J Steroid Biochem Mol Biol 2002, 83:113-118. 2. Mills E, Ernst E, et al.: Health food store recommendations:implications for breast cancer patients. Breast Cancer Res 2003, 5:170-174. 3. De Lemos M: Safety issues of soy phytoestrogens in breast cancer patients. J Clin Oncol 2002, 20:3040-3041. 4. Committee on Toxicology of Chemicals in Food, Consumer Products and the Environment. Phytoestrogens and Health. London: Food Standards Agency; 2003.